LIVE

Serial Number

97138333

Owner

Southern Scripts, LLC

Attorney

Kimra Major-Morris

First Use Date

Jan 2, 2022

Filing Date

Nov 22, 2021

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

RX COMPASS POWERED BY SOUTHERNSCRIPTS Trademark

Serial Number: 97138333 • Registration: 7340500

RX COMPASS POWERED BY SOUTHERNSCRIPTS is a trademark filed by Southern Scripts, LLC on November 22, 2021. The trademark is classified under Class 36 (Insurance & Financial). The application is currently registered and active.

Trademark Classes

Class 36 - Insurance & Financial

Insurance; financial affairs; monetary affairs; real estate affairs

Owner Contact Info

Southern Scripts, LLC (12 trademarks)

411 Bienville St.
Natchitoches, LA 71457

Entity Type: 16

Legal Representation

Attorney of Record

Kimra Major-Morris

639 trademarks filed View all →

Trademark Details

Filing Date

November 22, 2021

Registration Date

March 26, 2024

First Use Anywhere

January 2, 2022

First Use in Commerce

January 2, 2022

Published for Opposition

December 20, 2022

Goods & Services

Pharmaceutical benefit management services; Pharmacy benefit management services; Processing, administering and managing employee benefit plans concerning insurance and finance

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Mar 26, 2024 NRCC

REGISTERED-PRINCIPAL REGISTER

Mar 26, 2024 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Feb 17, 2024 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Feb 16, 2024 CNPR

EXAMINER'S AMENDMENT ENTERED

Feb 16, 2024 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Feb 16, 2024 GNEN

EXAMINERS AMENDMENT E-MAILED

Feb 16, 2024 GNEA

SU-EXAMINER'S AMENDMENT WRITTEN

Feb 16, 2024 SNEA

EXAMINER'S AMENDMENT ENTERED

Jan 19, 2024 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jan 19, 2024 GNEN

EXAMINERS AMENDMENT E-MAILED

Jan 19, 2024 GNEA

SU-EXAMINER'S AMENDMENT WRITTEN

Jan 19, 2024 SNEA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Sep 14, 2023 GNRN

NON-FINAL ACTION E-MAILED

Sep 14, 2023 GNRT

SU - NON-FINAL ACTION - WRITTEN

Sep 14, 2023 CNRT

STATEMENT OF USE PROCESSING COMPLETE

Aug 22, 2023 SUPC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Aug 22, 2023 AITU

USE AMENDMENT FILED

Aug 14, 2023 IUAF

TEAS STATEMENT OF USE RECEIVED

Aug 14, 2023 EISU

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Feb 14, 2023 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 20, 2022 NPUB

PUBLISHED FOR OPPOSITION

Dec 20, 2022 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Nov 30, 2022 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 17, 2022 CNSA

EXAMINER'S AMENDMENT ENTERED

Nov 14, 2022 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Nov 14, 2022 GNEN

EXAMINERS AMENDMENT E-MAILED

Nov 14, 2022 GNEA

EXAMINERS AMENDMENT -WRITTEN

Nov 14, 2022 CNEA

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 15, 2022 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 14, 2022 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 14, 2022 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Sep 7, 2022 GNRN

NON-FINAL ACTION E-MAILED

Sep 7, 2022 GNRT

NON-FINAL ACTION WRITTEN

Sep 7, 2022 CNRT

ASSIGNED TO EXAMINER

Sep 1, 2022 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Nov 30, 2021 MDSM

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 29, 2021 NWOS

NEW APPLICATION ENTERED

Nov 25, 2021 NWAP

Related Trademarks

More from this Owner

RXCOMPASS POWERED BY LIVINITI

VARIABLE COPAY

LIVINITI HEALTH

SOUTHERNSCRIPTS

More in Same Class